Found: 8
Select item for more details and to access through your institution.
Dual Time Point <sup>18</sup>F-FDG PET Imaging for Differentiating Malignant from Inflammatory Processes.
- Published in:
- Journal of Nuclear Medicine, 2001, v. 42, n. 9, p. 1412
- By:
- Publication type:
- Article
The Promising Role of <sup>18</sup>F-FDG PET in Detecting Infected Lower Limb Prosthesis Implants.
- Published in:
- Journal of Nuclear Medicine, 2001, v. 42, n. 1, p. 44
- By:
- Publication type:
- Article
Correction to: Quantitative Systems Pharmacology Modeling of Avadomide-Induced Neutropenia Enables Virtual Clinical Dose and Schedule Finding Studies.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Quantitative Systems Pharmacology Modeling of Avadomide-Induced Neutropenia Enables Virtual Clinical Dose and Schedule Finding Studies.
- Published in:
- AAPS Journal, 2021, v. 23, n. 5, p. 1, doi. 10.1208/s12248-021-00623-8
- By:
- Publication type:
- Article
<sup>18</sup>F-FDG PET in malignant lymphoma: significance of positive findings.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2005, v. 32, n. 7, p. 749, doi. 10.1007/s00259-004-1748-x
- By:
- Publication type:
- Article
Population Pharmacokinetics of CC-122.
- Published in:
- Clinical Pharmacology, 2021, v. 13, p. 61, doi. 10.2147/CPAA.S310604
- By:
- Publication type:
- Article
Model based assessment of food and acid reducing agent effects on oral absorption of mezigdomide (CC‐92480), a novel cereblon E3 ligase modulator.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2023, v. 12, n. 10, p. 1473, doi. 10.1002/psp4.13024
- By:
- Publication type:
- Article
Phase I, multicenter, dose‐escalation study of avadomide in adult Japanese patients with advanced malignancies.
- Published in:
- Cancer Science, 2021, v. 112, n. 1, p. 331, doi. 10.1111/cas.14704
- By:
- Publication type:
- Article